v3.25.4
Financial Instruments (Tables)
 12 Months Ended
Dec. 27, 2025
Derivative Instruments and Hedges, Assets [Abstract]  
Schedule of Notional Amounts of Outstanding
The notional amounts of our financial instruments used to hedge the above risks as of December 27, 2025 and December 28, 2024 are as follows:
 
Notional Amounts(a)
20252024
Commodity contracts$1.5 $1.4 
Interest rate swap contracts$2.0 $2.0 
Foreign exchange contracts (b)
$3.1 $3.1 
Cross-currency contracts$1.7 $1.2 
Non-derivative debt instruments (b)
$4.4 $2.9 
(a)In billions.
(b)Subsequent to December 27, 2025, we designated $1.6 billion of foreign exchange contracts maturing in February 2026 and $4.5 billion of existing euro denominated debt as net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.
Fair Values Of Financial Assets And Liabilities
The fair values of our financial assets and liabilities as of December 27, 2025 and December 28, 2024 are categorized as follows:
 20252024
 
Fair Value Hierarchy Levels(a)
Assets(a)
Liabilities(a)
Assets(a)
Liabilities(a)
Available-for-sale debt securities (b)
3$2,127 $— $1,041 $— 
Index funds (c)
1341 — 336 — 
Deferred compensation (d)
2— 495 — 503 
Contingent consideration (e)
3— 278 — — 
Derivatives designated as fair value hedging instruments:
Interest rate swap contracts (f)
219 3 — 46 
Derivatives designated as cash flow hedging instruments:
Foreign exchange contracts (g)
26 28 55 3 
Cross-currency contracts (g)
2— 102 — 165 
Commodity contracts (h)
2116 5 27 6 
122 135 82 174 
Derivatives designated as net investment hedging instruments:
Foreign exchange contracts (g)
2— 1 — — 
Cross-currency contracts (g)
2— 34 1 4 
— 35 1 4 
Derivatives not designated as hedging instruments:
Foreign exchange contracts (g)
26 32 28 12 
Commodity contracts (h)
24 9 3 10 
10 41 31 22 
Total derivatives at fair value (i)
151 214 114 246 
Total$2,619 $987 $1,491 $749 
(a)Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.
(b)Classified as other assets. The fair value of our investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 8.5% and 7.3% as of December 27, 2025 and December 28, 2024, respectively. The fair value of the other investment is estimated using a lattice model primarily based on the underlying stock price, volatility and certain significant unobservable inputs, such as a discount rate of 8.3% based on an estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement.
(c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.
(d)Based on the fair value of investments corresponding to employees’ investment elections.
(e)In connection with our acquisition of poppi, we recorded a liability at fair value for the contingent consideration payable upon achievement of certain performance milestones by the third quarter of 2027, with a maximum payment of $300 million. If these performance milestones are not met, no payment will be made. The fair value of the liability is estimated using discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as forecasts of net revenue and margin. An increase in the net revenue and margin forecasts would result in a higher fair value measurement, while a decrease in the net revenue and margin forecasts would result in a lower fair value measurement. As of December 27, 2025, the fair value of the contingent consideration was $278 million, comprised of the acquisition date fair value of $180 million and a fair value increase of $98 million recorded in selling, general and administrative expenses.
(f)Based on Secured Overnight Financing Rate forward rates. As of December 27, 2025, the carrying amount of hedged fixed-rate debt was $2.0 billion, which was classified on the balance sheet within long-term debt obligations.
(g)Based on recently reported market transactions of spot and/or forward rates.
(h)Primarily based on recently reported market transactions of swap arrangements.
(i)Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of December 27, 2025 and December 28, 2024 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table.
Effective Portion Of Pre-Tax (Gains)/Losses On Derivative Instruments
Losses/(gains) on our fair value hedges recognized in the income statement are as follows:
20252024
Interest rate swap contracts (a)
$(62)$46 
(a)Interest rate derivative losses/(gains) are included in net interest expense and other. These losses/(gains) are substantially offset by decreases/increases in the value of the underlying debt, which are also included in net interest expense and other.
Losses/(gains) on our cash flow hedges are categorized as follows:
 Losses/(Gains)
Recognized in
Accumulated Other
Comprehensive Loss
Losses/(Gains)
Reclassified from
Accumulated Other
Comprehensive Loss
into Income
Statement(a)
2025202420252024
Foreign exchange contracts$95 $(101)$12 $(6)
Cross-currency contracts(63)46 (67)48 
Commodity contracts(218)57 (77)123 
Total$(186)$2 $(132)$165 
(a)Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information.
Losses/(gains) on our net investment hedges are categorized as follows:
 Losses/(Gains)
Recognized in
Accumulated Other
Comprehensive Loss
Losses/(Gains)
 Recognized in Income Statement(a)
2025202420252024
Non-derivative debt instruments$337 $(133)$— $— 
Cross-currency contracts33 3 (13)(5)
Foreign exchange contracts(13)— — — 
Total$357 $(130)$(13)$(5)
(a)Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps and
forward contracts.
Derivatives Not Designated as Hedging Instruments
Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:
20252024
Cost of salesSelling, general and administrative expensesTotalCost of salesSelling, general and administrative expensesTotal
Foreign exchange contracts$1 $66 $67 $1 $2 $3 
Commodity contracts16 6 22 2 8 10 
Total$17 $72 $89 $3 $10 $13 
Debt Securities, Available-for-Sale
The activity related to our Level 3 investments in certain available-for-sale debt securities is as follows:
20252024
Celsius:
Balance, beginning of year$785 $1,156 
Acquired590 — 
Net unrealized gain/(loss)507 (350)
Cash dividends received(30)(21)
Balance, end of year1,852 785 
Other:
Balance, beginning of year256 — 
Transfer from Level 2 (a)
— 184 
Net unrealized gain19 72 
Balance, end of year275 256 
Total Level 3 available-for-sale balance, end of year$2,127 $1,041 
(a)Unobservable inputs to the fair value became more significant.